#  John D. Young 

###  Board member since 2023 

 

 ![John D. Young, Board member](/sites/novartis_com/files/styles/biography_detail_image_v2/public/2026-06/john-young-bio-1170.jpg?h=4cf895d5&itok=HykBqKqw "John D. Young, Board member") 

 

 

**Nationality**: British/American | **Year of birth**: 1964

A scientist by training, John D. Young has over 35 years of experience in the healthcare industry and brings a wealth of experience in leadership, strategy, business development and commercialization of innovative medicines to the Novartis Board of Directors. He joined Pfizer in 1987 as a sales representative and held positions of increasing seniority across the company, including as a member of Pfizer’s executive leadership team for a decade. As Pfizer’s group president and chief business officer from 2019 until 2022, Mr. Young also played an integral role in the development and delivery of the Pfizer-BioNTech COVID-19 vaccine.

### Professional experience

- Senior advisor to the CEO, Pfizer, US (2022)
- Group president and chief business officer, Pfizer, US (2019-2022)
- Group president, innovative health business, Pfizer, US (2018)
- Group president, essential health business, Pfizer, US (2014-2017)
- President and general manager, global primary care business unit, Pfizer, US (2012-2013)
- Regional president, primary care business unit for Europe and Canada, Pfizer, UK (2009-2012)
- Various managerial positions, Pfizer, UK and Australia (1987–2008)

### Mandates

##### Current:

- Board member and chair of the compensation and talent development committee, Johnson Controls International, Ireland

##### Past:

- Board member and chair of the compensation committee, Arvinas Inc, US (2022-2025)
- Board member, Imbria Pharmaceuticals, US (2022-2024)
- Board member, Haleon, UK (2022-2023)
- Board member, GSK Consumer Health Joint Venture, UK (2019-2022)
- Board member, Biotechnology Innovation Organization (BIO), US (2018-2021)
- US bio-pharmaceutical representative, UK Government Life Sciences Council, UK (2007-2021)
- Board member, National Committee for US China Relations, US (2014-2017)
- Board member, European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium (2012-2017)

### Education

- Master of business administration, University of Strathclyde, UK
- Bachelor’s degree in biological sciences, University of Glasgow, UK

### Key skills

- Medicine/healthcare/R&D
- Leadership/management
- Commercial
- Finance/accounting
- Regulatory/risk management



 



 

 

 



 

 



##  Novartis media library assets 

 [ 

 ![John D. Young, Board member](/sites/novartis_com/files/styles/cards_1_3/public/2026-06/john-young-media-library-1.jpg.webp?itok=hs2gxUrm "John D. Young, Board member") 

 

###  John D. Young 

Board member

 

 

 ](/news/media-library/john-d-young-0) [ 

 ![John D. Young, Board member](/sites/novartis_com/files/styles/cards_1_3/public/2026-06/john-young-media-library-2.jpg.webp?itok=n3xpfv_r "John D. Young, Board member") 

 

###  John D. Young 

Board member

 

 

 ](/news/media-library/john-d-young-1)